NF-κB is involved in regulation of CD40 ligand expression on Mycobacterium bovis bacillus Calmette-Guérin-activated human T cells

Clinical and Diagnostic Laboratory Immunology

Volumn 10, Issue 3, 2003, Pages 376-382

  Méndez Samperio, Patricia ^a   Ayala, Hilda ^a   Vázquez, Abraham ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; CALCIUM ION; CD4 ANTIGEN; CD40 ANTIGEN; I KAPPA B ALPHA; I KAPPA B BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROTEIN KINASE C INHIBITOR; PROTEINASE INHIBITOR; ROTTLERIN; SALICYLIC ACID; CD40 LIGAND; I KAPPA B; PROTEIN KINASE C;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; BACTERIAL STRAIN; CELL SURFACE; CONTROLLED STUDY; DNA BINDING; DOWN REGULATION; HUMAN; HUMAN CELL; MYCOBACTERIUM BOVIS; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; PROTEINASE INHIBITION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TRANSCRIPTION REGULATION; UPREGULATION; ADULT; BIOSYNTHESIS; CELL CULTURE; GENE EXPRESSION REGULATION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MICROBIOLOGY; PHOSPHORYLATION; PHYSIOLOGY;

ADULT; CD40 LIGAND; CELLS, CULTURED; GENE EXPRESSION REGULATION; HUMANS; I-KAPPA B PROTEINS; LYMPHOCYTE ACTIVATION; MYCOBACTERIUM BOVIS; NF-KAPPA B; PHOSPHORYLATION; PROTEIN KINASE C; T-LYMPHOCYTES;

EID: 1542754095     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.10.3.376-382.2003     Document Type: Article

References (42)

1. Armitage, R. J., C. R. Maliszewski, M. R. Alderson, K. H. Grabstein, M. K. Spriggs, and W. C. Fanslow. 1993. CD40L: a multi-functional ligand. Semin. Immunol. 5:401-412.
2. Armitage, R. J., W. C. Fanslow, L. Strockbine, T. A. Sato, K. N. Clifford, B. M. Mcduff, D. M. Anderson, S. D. Gimpel, T. Davis-Smith, C. R. Maliszewski, E. A. Clark, C. A. Smith, K. H. Grabstein, D. Cosman, and M. K. Spriggs. 1992. Molecular and biological characterization of a murine ligand for CD40. Nature 357:80-82.
3. Baeuerle, P., and T. Henkel. 1994. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol. 12:141-179.
4. Barnhart, B., P. A. Kosinski, Z. Wang, G. S. Ford, M. Kiledjian, and L. R. Covey. 2000. Identification of a complex that binds to the CD154 3′ untranslated region: implications for a role in message stability during T cell activation. J. Immunol. 165:4478-4486.
5. Brown, M. C., and S. M. Taffet. 1995. Lipoarabinomannans derived from different strains of Mycobacterium tuberculosis differentially stimulate the activation of NF-κB and KBF1 in murine macrophages. Infect. Immun. 63:1960-1968.
6. Cheng, J. D., R. P. Ryseck, R. M. Attar, D. Dambach, and R. Bravo. 1998. Functional redundancy of the nuclear factor κB inhibitors IκBα and IκBβ. J. Exp. Med. 188:1055-1062.
7. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
8. Coudronniere, N., M. Villalba, N. Englund, and A. Altman. 2000. NF-κB activation induced by T cell receptor/CD28 costimulation is mediated by protein kinase C-θ. Proc. Natl. Acad. Sci. USA 97:3394-3399.
9. Ferlin, W. G., T. Vonderweid, F. Cottrez, D. A. Ferrick, R. L. Coffman, and M. C. Howard. 1998. The induction of a protective response in Leishmania major-infected BALB/c mice with anti-CD40 monoclonal antibody. Eur. J. Immunol. 28:525-531.
10. Finco, T. S., A. A. Beg, and A. S. Baldwin, Jr. 1994. Inducible phosphorylation of IκB-α is not sufficient for its dissociation from NF-κB and is inhibited by protease inhibitors. Proc. Natl. Acad. Sci. USA 91:11884-11888.
11. Ghosh, S., M. J. May, and E. B. Kopp. 1998. NF-κB and REL proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:225-260.
12. Grewal, I. S., and R. A. Flavell. 1997. The CD40 ligand. At the center of the immune universe? Immunol. Res. 16:59-70.
13. Grewal, I. S., and R. A. Flavell. 1996. A central role of CD40 ligand in the regulation of CD4+ T-cell responses. Immunol. Today 17:410-414.
14. Grewal, I. S., and R. A. Flavell. 1998. CD40 and CD154 in cell-mediated immunity. Annu. Rev. Immunol. Res. 16:111-135.
15. Grewal, I. S., P. Borrow, E. G. Pamer, M. B. A. Oldstone, and R. A. Flavell. 1997. The CD40-CD154 system in anti-infective host defense. Curr. Opin. Immunol. 9:491-497.
16. Gurunathan, S., K. R. Irvine, C. Y. Wu, J. I. Cohen, E. Thomas, C. Prussin, N. P. Restifo, and R. A. Seder. 1998. CD40 ligand trimer DNA enhances both humoral and cellular immune responses and induces protective immunity to infectious and tumor challenge. J. Immunol. 161:4563-4571.
17. Kennedy, M. K., K. S. Picha, W. C. Fanslow, K. H. Grabstein, M. R. Alderson, K. N. Clifford, W. A. Chin, and K. M. Mohler. 1996. CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages. Eur. J. Immunol. 26:370-378.
18. Kopp, E., and S. Ghosh. 1994. Inhibition of NF-κB by sodium salicylate and aspirin. Science 265:956-959.
19. Kunsch, C., S. M. Ruben, and C. A. Rosen. 1992. Selection of optimal kappa B/Rel DNA-binding motifs: interaction of both subunits of NF-kappa B with DNA is required for transcriptional activation. Mol. Cell. Biol. 12:4412-4421.
20. Lederman, S., M. J. Yellin, A. Krichevsky, J. Belko, J. J. Lee, and L. Chess. 1992. Identification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help). J. Exp. Med. 175:1091-1101.
21. Lee, B. O., L. Haynes, S. M. Eaton, S. L. Swain, and T. D. Randall. 2002. The biological outcome of CD40 signaling is dependent on the duration of CD40 ligand expression: reciprocal regulation by interleukin (IL)-4 and IL-12. J. Exp. Med. 196:693-704.
22. Lindroos, P. M., A. B. Rice, Y. Z. Wang, and J. C. Bonner. 1998. Role of nuclear factor-kappa B and mitogen-activated protein kinase signaling pathways in IL-1 beta-mediated induction of alpha-PDGF receptor expression in rat pulmonary myofibroblasts. J. Immunol. 161:3463-3468.
23. Meyer, M., R. Schreck, and P. A. Baeuerle. 1993. H2O2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J. 12:2005-2015.
24. Murphy, T. L., M. G. Cleveland, P. Kulesza, J. M. Magram, and K. M. Murphy. 1995. Regulation of interleukin-12 p40 expression through an NF-κB half-site. Mol. Cell. Biol. 15:5258-5267.
25. Newton, A. C. 1997. Regulation of protein kinase C. Curr. Opin. Cell Biol. 9:161-167.
26. Noelle, R. J. 1996. CD40 and its ligand in host defense. Immunity 4:415-419.
27. Nüsslein, H. G., K. Frosch, W. Woith, P. Lane, J. Kalden, and B. Manger. 1996. Increase of intracellular calcium is the essential signal for the expression of CD40 ligand. Eur. J. Immunol. 26:846-850.
28. Perkins, N. 1995. Achieving transcriptional specificity with NF-κB. Int. J. Biochem. Cell Biol. 29:1433-1448.
29. Pierce, J. W., M. A. Read, H. Ding, F. W. Luscinskas, and T. Collins. 1996. Salicylates inhibit IKβ-α phosphorylation, endothelial-leukocyte adhesion molecule expression, and neutrophil transmigration. J. Immunol. 156:3961-3969.
30. Read, M. A., A. S. Neish, F. W. Luscinskas, V. J. Palombella, T. Maniatis, and T. Collins. 1995. The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression. Immunity 2:493-506.
31. Roy, M., A. Aruffo, J. A. Ledbetter, P. Linsley, M. Kehry, and R. J. Noelle. 1995. Studies on the independence of gp39 and B7 expression and function during antigen-specific immune responses. Eur. J. Immunol. 25:596-603.
32. Roy, M., T. Waldschmidt, A. Aruffo, J. A. Ledbetter, and R. J. Noelle. 1993. The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells. J. Immunol. 151:2497-2510.
33. Schubert, L. A., G. King, R. Q. Cron, D. B. Lewis, A. Aruffo, and D. Hollenbaugh. 1995. The human gp39 promoter. Two distinct nuclear factors of activated T cell protein-binding elements contribute independently to transcriptional activation. J. Biol. Chem. 270:29624-29627.
34. Smiley, S. T., V. Csizmadia, W. Gao, L. A. Turka, and W. W. Hancock. 2000. Differential effects of cyclosporine A, methylprednisolone, mycophenolate, and rapamycin on CD154 induction and requirement for NF-kappaB: implication for tolerance induction. Transplantation 70:415-419.
35. Sun, Z., C. W. Arendt, W. Ellmeier, E. M. Schaeffer, M. J. Sunshine, L. Gandhi, J. Annes, D. Petrzilka, A. Kupfer, P. L. Schwartzberg, and D. R. Littman. 2000. PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes. Nature 404:402-407.
36. Thanos, D., and T. Maniatis. 1995. NF-κB: a lesson in family values. Cell 80:529-532.
37. Toossi, Z., B. D. Hamilton, M. H. Phillips, L. E. Averill, J. J. Ellner, and A. Salveker. 1997. Regulation of nuclear factor-kappa B and its inhibitor I kappa B-alpha/MAD-3 in monocytes by Mycobacterium tuberculosis and during human tuberculosis. J. Immunol. 15:4109-4116.
38. Tschou-Wong, K. M., O. Tanabe, C. Chi, T. A. Yie, and W. N. Rom. 1999. Activation of NF-κB in Mycobacterium tuberculosis-induced interleukin-2 receptor expression in mononuclear phagocytes. Am. J. Respir. Crit. Care Med. 159:1323-1329.
39. Tsytsykova, A. V., E. N. Tsitsikov, and R. S. Geha. 1996. The CD40 L promoter contains nuclear factor of activated T cells-binding motifs which require AP-1 binding for activation of transcription. J. Biol. Chem. 271:3763-3770.
40. Verma, I. M., J. K. Stevenson, E. M. Schwarz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-kappa B/I kappa family: intimate tales of association and dissociation. Genes Dev. 9:2723-2735.
41. Wickremasinghe, M. I., L. H. Thomas, and J. S. Friedland. 1999. Pulmonary epithelial cells are a source of IL-8 in the response to Mycobacterium tuberculosis: essential role of IL-1 from infected monocytes in a NF-kappa B-dependent network. J. Immunol. 163:3936-3947.
42. Zhang, Y., M. Broser, and W. N. Rom. 1995. Activation of the interleukin 6 gene by Mycobacterium tuberculosis of lipopolysaccharide is mediated by nuclear factor NF-IL-6 and NF-kappa B. Proc. Natl. Acad. Sci. USA 91:2225-2229.